|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,201 KRW | -0.25% |
|
-1.40% | -66.50% |
OliX Pharmaceuticals, Inc (KOSDAQ:A226950) agreed to acquire 6.63% stake in PCL, Inc. (KOSDAQ:A241820) for KRW8.04 billion on November 11, 2022.
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 15,220 KRW | -0.59% | +1.67% | 183M | ||
| 1,201 KRW | -0.25% | -1.40% | 47.15M | ||
| 1st Jan change | Capi. | |
|---|---|---|
| -66.50% | 47.15M | |
| -20.45% | 10.82B | |
| +43.17% | 3.25B | |
| -35.86% | 2.11B | |
| -17.21% | 2.08B | |
| -29.81% | 1.48B | |
| +17.56% | 1.02B | |
| -4.37% | 733M | |
| -37.00% | 391M | |
| -46.94% | 377M |
PCL, INC. 
